Literature DB >> 24587684

Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis.

Evangeli S Lampri1, Elli Ioachim1, Haralampos Harissis1, Eufemia Balasi1, Antigoni Mitselou1, Vasiliki Malamou-Mitsi1.   

Abstract

Hepatocellular carcinoma (HCC) often develops in patients with underlying liver disease, yet HCC with syncytial giant cells (SGCs) is extremely rare. Herein, we report a 55-year-old man with a 6-year history of alcoholic cirrhosis who during his regular checkup presented with marked elevation of alpha-fetoprotein. Clinical examination and imaging analyses revealed a tumor-like lesion in segment 4 of the liver, which was removed by limited wedge resection. Histological analysis by hematoxylin and eosin staining indicated pleomorphic and atypical nodules, with some SGCs, embedded within the boundaries of the neoplastic lesion. The adjacent liver parenchyma showed microvesicular steatosis, pericellular fibrosis, and moderate hemosiderin accumulation (grade 2, as determined by Prussian blue iron stain) in hepatocytes and Kupffer cells but no copper accumulation (as determined by orcein stain). Immunohistochemical analysis showed hepatocyte antigen-positive staining for the neoplastic cells and SGCs. The diagnosis was made for cirrhosis-related HCC with SGCs. The previous reports of pleomorphic HCC have featured osteoclast-like (i.e., mesenchymal type) giant cells, making this case of epithelial type giant cells very rare. The patient's 6-month history of hypericum perforatum/St John's wort self-medication may have prompted the cirrhosis or HCC progression or the unusual SGC manifestation.

Entities:  

Keywords:  Alcoholic cirrhosis; Giant cell carcinoma; Hepatocellular carcinoma; Hypericum perforatum; Pleomorphic liver tumor; St John’s wort; Syncytial giant cell

Mesh:

Substances:

Year:  2014        PMID: 24587684      PMCID: PMC3934483          DOI: 10.3748/wjg.v20.i8.2113

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  St John's wort for depression: a systematic review.

Authors:  B Gaster; J Holroyd
Journal:  Arch Intern Med       Date:  2000-01-24

2.  St John's wort helps to fight bladder cancer.

Authors:  C Orellane
Journal:  Lancet Oncol       Date:  2001-07       Impact factor: 41.316

Review 3.  Pharmacokinetic interactions between herbal remedies and medicinal drugs.

Authors:  C Ioannides
Journal:  Xenobiotica       Date:  2002-06       Impact factor: 1.908

4.  The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells.

Authors:  Dimitris Skalkos; Nikolaos E Stavropoulos; Ioannis Tsimaris; Eleni Gioti; Constantine D Stalikas; Unyime O Nseyo; Elli Ioachim; Niki J Agnantis
Journal:  Planta Med       Date:  2005-11       Impact factor: 3.352

5.  St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.

Authors:  L B Moore; B Goodwin; S A Jones; G B Wisely; C J Serabjit-Singh; T M Willson; J L Collins; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Hepatocellular carcinoma, syncytial giant cell: a novel variant in children: a case report.

Authors:  A Atra; R Al-Asiri; S Wali; H Al-Husseini; A Al-Bassas; A Zimmermann
Journal:  Ann Diagn Pathol       Date:  2007-02       Impact factor: 2.090

7.  Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.

Authors:  Marina Perfumi; Laura Mattioli; Marino Cucculelli; Maurizio Massi
Journal:  J Psychopharmacol       Date:  2005-09       Impact factor: 4.153

8.  Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.

Authors:  Christoph M Schempp; Vladimir Kirkin; Birgit Simon-Haarhaus; Astrid Kersten; Judit Kiss; Christian C Termeer; Bernhard Gilb; Thomas Kaufmann; Christoph Borner; Jonathan P Sleeman; Jan C Simon
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

9.  Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.

Authors:  Lavinia Cantoni; Marco Rozio; Alessandra Mangolini; Lisa Hauri; Silvio Caccia
Journal:  Toxicol Sci       Date:  2003-07-11       Impact factor: 4.849

10.  [Hypericum perforatum extract in treatment of mild to moderate depression. Clinical and pharmacological aspects].

Authors:  G Laakmann; G Jahn; C Schüle
Journal:  Nervenarzt       Date:  2002-07       Impact factor: 1.214

View more
  1 in total

1.  Does St. John's Wort cause regression in gastrointestinal system adenocarcinomas?

Authors:  Serap Karaarslan; Suna Cokmert; Atilla Cokmez
Journal:  World J Gastrointest Oncol       Date:  2015-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.